AMP 2019 Annual Meeting & Expo

November 7 - 9, 2019

Corporate Workshop Day: November 6, 2019

Baltimore Convention Center, Baltimore, MD
Booth #2813

Learn More

Come listen to our Corporate Workshop on November 6th @11:00am

Title: AVENIO ctDNA Clinical Research Story: Surveillance & Monitoring
 
Speaker: Timothy R. Schwartz, Ph.D., Senior Scientific Affairs Manager,
Medical and Scientific Affairs - US, Roche Diagnostics Corporation
 
Date: Wednesday, November 6, 2019
Time: 11:00 am - 11:50 am
Room: 327 - 329
 
Description: There are multiple challenges present in the disease monitoring of solid tumors; treatment options are available but broadly-applicable disease monitoring is not yet established. The AVENIO NGS Surveillance kit enabled by CAPP-Seq technology is proven to be feasible in ctDNA-based monitoring of lung and colorectal cancers, moving toward ctDNA-guided disease management. This workshop will discuss clinical research results using the AVENIO somatic oncology kits, minimal residual disease (MRD) detection through ctDNA analysis, disease monitoring starting with and without matched tissue biopsies, and future opportunities for AVENIO assays in clinical cancer research.

Stop by Booth 2813 to learn about these Roche solutions and more

AVENIO NGS Assays for Clinical Research

AVENIO family of NGS oncology assays for plasma and FFPE tumor tissue provide a dynamic, comprehensive genomic profile of solid tumors through the analysis of both ctDNA and FFPE tumor tissue.

For Research Use Only. Not for Use in Diagnostic Procedures.

Learn More

AVENIO Millisect System

The AVENIO Millisect System is an automated, high-performance tissue dissection system that enables precise and consistent recovery of formalin-fixed paraffin-embedded (FFPE) tissue areas of interest for molecular pathology. The system is optimized to fit easily into a variety of clinical workflow configurations, improve diagnostic testing results by reducing false negatives, and help you efficiently extract more clinically relevant information from every sample.

Learn More

MagNA Pure 24 System

The MagNA Pure 24 instrument was constructed around the diverse needs of modern laboratories. This system enhances your nucleic acid workflow with easy-to-use features such as:

  • Single universal reagent kit for 9 prevalidated human sample types
  • Primary sample input, with mixed-sample batching
  • Scalable extraction of 1 – 24 samples
  • Extraction of up to 24 samples in 70 minutes, or 8 samples in 30 minutes
  • Volume inputs ranging from 200 μL to 4 mL
  • Sample and inventory tracking via barcoded surveillance
  • Resealable reagent kits to reduce waste
  • IVD labeled with barcoded onboard surveillance to track liquid levels, extraction inventory, and sample clots
Learn More